Search / 667 results found

from
to
  • Updated

Police across the Tri-Cities, Yakima, and surrounding areas are ready to collect all unwanted prescriptions and over-the-counter medication as part of National Drug Take Back Day.

  • Updated

TOKYO and BOTHELL, Wash., Sept. 27, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved PADCEV® (enfortumab vedotin) for radically unresectable urothelial carcinoma that has progressed after anti-cancer chemotherapy. The New Drug Application received priority review.